US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 1.170
  • -0.110-8.59%
Close Apr 19 16:00 ET
  • 1.190
  • +0.020+1.71%
Post 17:06 ET
134.63MMarket Cap-936P/E (TTM)

Karyopharm Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-7.03%146.03M
0.50%33.75M
-0.38%36.01M
-5.29%37.58M
-18.82%38.7M
-25.14%157.07M
-73.41%33.58M
-4.10%36.15M
75.56%39.68M
104.94%47.67M
Operating revenue
-7.03%146.03M
0.50%33.75M
-0.38%36.01M
-5.29%37.58M
-18.82%38.7M
-25.14%157.07M
-73.41%33.58M
-4.10%36.15M
75.56%39.68M
104.94%47.67M
Cost of revenue
-5.20%4.94M
-20.45%1.49M
-7.04%911K
27.16%1.19M
-5.26%1.35M
53.23%5.21M
151.75%1.87M
66.38%980K
-17.49%939K
52.84%1.43M
Gross profit
-7.09%141.09M
1.73%32.26M
-0.19%35.1M
-6.08%36.39M
-19.24%37.35M
-26.43%151.86M
-74.74%31.71M
-5.22%35.17M
80.50%38.74M
107.12%46.24M
Operating expense
-7.97%270.63M
6.84%70.07M
0.54%66.36M
-19.22%65.96M
-15.57%68.25M
-3.49%294.06M
-16.53%65.58M
-18.42%66M
15.79%81.65M
8.21%80.83M
Selling and administrative expenses
-9.30%131.88M
-11.43%30.69M
-11.08%30.81M
-7.65%34.48M
-7.38%35.91M
1.08%145.4M
0.25%34.65M
-1.31%34.65M
2.21%37.34M
2.97%38.77M
-General and administrative expense
-9.30%131.88M
-11.43%30.69M
-11.08%30.81M
-7.65%34.48M
-7.38%35.91M
1.08%145.4M
0.25%34.65M
-1.31%34.65M
2.21%37.34M
2.97%38.77M
Research and development costs
-6.67%138.75M
27.31%39.38M
13.37%35.55M
-28.96%31.48M
-23.12%32.34M
-7.57%148.66M
-29.70%30.93M
-31.54%31.36M
30.39%44.31M
13.53%42.06M
Operating profit
8.90%-129.54M
-11.63%-37.81M
-1.37%-31.26M
31.08%-29.57M
10.66%-30.9M
-44.70%-142.2M
-172.12%-33.87M
29.61%-30.84M
12.52%-42.91M
33.96%-34.59M
Net non-operating interest income expense
43.10%-12.88M
18.96%-3.69M
39.09%-3.32M
50.83%-2.96M
55.99%-2.91M
11.10%-22.64M
42.28%-4.55M
31.04%-5.46M
-24.48%-6.02M
-36.82%-6.61M
Non-operating interest income
363.88%10.94M
88.91%2.52M
317.93%2.75M
863.82%2.82M
3,750.00%2.85M
305.33%2.36M
2,325.45%1.33M
571.43%658K
77.58%293K
-71.97%74K
Non-operating interest expense
-4.69%23.82M
5.49%6.21M
-0.67%6.07M
-8.38%5.78M
-13.85%5.76M
-4.03%25M
-25.88%5.89M
-23.67%6.11M
26.23%6.31M
31.19%6.68M
Other net income (expense)
-328.92%-356K
-1,523.08%-211K
456.25%89K
330.77%30K
-261.64%-264K
2.35%-83K
97.28%-13K
-11.11%16K
-102.98%-13K
-19.67%-73K
Gain on sale of security
----
----
----
----
-261.64%-264K
----
----
----
----
---73K
Other non- operating income (expenses)
-328.92%-356K
-1,523.08%-211K
456.25%89K
330.77%30K
----
2.35%-83K
97.28%-13K
-11.11%16K
-102.98%-13K
----
Income before tax
13.43%-142.78M
-8.52%-41.71M
4.92%-34.49M
33.59%-32.5M
17.44%-34.07M
-33.19%-164.92M
-199.57%-38.43M
29.84%-36.28M
8.43%-48.94M
27.93%-41.27M
Income tax
-12.47%323K
78.08%130K
-73.33%12K
4.96%127K
-58.46%54K
37.69%369K
160.33%73K
-57.55%45K
-9.70%121K
-12.75%130K
Net income
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
27.89%-41.4M
Net income continuous Operations
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
27.89%-41.4M
Minority interest income
Net income attributable to the parent company
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
27.89%-41.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
27.89%-41.4M
Basic earnings per share
38.12%-1.25
16.28%-0.36
33.33%-0.3
53.23%-0.29
43.40%-0.3
-22.42%-2.02
-184.31%-0.43
34.78%-0.45
12.68%-0.62
31.17%-0.53
Diluted earnings per share
38.12%-1.25
16.28%-0.36
33.33%-0.3
53.23%-0.29
43.40%-0.3
-22.42%-2.02
-193.48%-0.43
34.78%-0.45
12.68%-0.62
31.17%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -7.03%146.03M0.50%33.75M-0.38%36.01M-5.29%37.58M-18.82%38.7M-25.14%157.07M-73.41%33.58M-4.10%36.15M75.56%39.68M104.94%47.67M
Operating revenue -7.03%146.03M0.50%33.75M-0.38%36.01M-5.29%37.58M-18.82%38.7M-25.14%157.07M-73.41%33.58M-4.10%36.15M75.56%39.68M104.94%47.67M
Cost of revenue -5.20%4.94M-20.45%1.49M-7.04%911K27.16%1.19M-5.26%1.35M53.23%5.21M151.75%1.87M66.38%980K-17.49%939K52.84%1.43M
Gross profit -7.09%141.09M1.73%32.26M-0.19%35.1M-6.08%36.39M-19.24%37.35M-26.43%151.86M-74.74%31.71M-5.22%35.17M80.50%38.74M107.12%46.24M
Operating expense -7.97%270.63M6.84%70.07M0.54%66.36M-19.22%65.96M-15.57%68.25M-3.49%294.06M-16.53%65.58M-18.42%66M15.79%81.65M8.21%80.83M
Selling and administrative expenses -9.30%131.88M-11.43%30.69M-11.08%30.81M-7.65%34.48M-7.38%35.91M1.08%145.4M0.25%34.65M-1.31%34.65M2.21%37.34M2.97%38.77M
-General and administrative expense -9.30%131.88M-11.43%30.69M-11.08%30.81M-7.65%34.48M-7.38%35.91M1.08%145.4M0.25%34.65M-1.31%34.65M2.21%37.34M2.97%38.77M
Research and development costs -6.67%138.75M27.31%39.38M13.37%35.55M-28.96%31.48M-23.12%32.34M-7.57%148.66M-29.70%30.93M-31.54%31.36M30.39%44.31M13.53%42.06M
Operating profit 8.90%-129.54M-11.63%-37.81M-1.37%-31.26M31.08%-29.57M10.66%-30.9M-44.70%-142.2M-172.12%-33.87M29.61%-30.84M12.52%-42.91M33.96%-34.59M
Net non-operating interest income expense 43.10%-12.88M18.96%-3.69M39.09%-3.32M50.83%-2.96M55.99%-2.91M11.10%-22.64M42.28%-4.55M31.04%-5.46M-24.48%-6.02M-36.82%-6.61M
Non-operating interest income 363.88%10.94M88.91%2.52M317.93%2.75M863.82%2.82M3,750.00%2.85M305.33%2.36M2,325.45%1.33M571.43%658K77.58%293K-71.97%74K
Non-operating interest expense -4.69%23.82M5.49%6.21M-0.67%6.07M-8.38%5.78M-13.85%5.76M-4.03%25M-25.88%5.89M-23.67%6.11M26.23%6.31M31.19%6.68M
Other net income (expense) -328.92%-356K-1,523.08%-211K456.25%89K330.77%30K-261.64%-264K2.35%-83K97.28%-13K-11.11%16K-102.98%-13K-19.67%-73K
Gain on sale of security -----------------261.64%-264K-------------------73K
Other non- operating income (expenses) -328.92%-356K-1,523.08%-211K456.25%89K330.77%30K----2.35%-83K97.28%-13K-11.11%16K-102.98%-13K----
Income before tax 13.43%-142.78M-8.52%-41.71M4.92%-34.49M33.59%-32.5M17.44%-34.07M-33.19%-164.92M-199.57%-38.43M29.84%-36.28M8.43%-48.94M27.93%-41.27M
Income tax -12.47%323K78.08%130K-73.33%12K4.96%127K-58.46%54K37.69%369K160.33%73K-57.55%45K-9.70%121K-12.75%130K
Net income 13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M27.89%-41.4M
Net income continuous Operations 13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M27.89%-41.4M
Minority interest income
Net income attributable to the parent company 13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M27.89%-41.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M27.89%-41.4M
Basic earnings per share 38.12%-1.2516.28%-0.3633.33%-0.353.23%-0.2943.40%-0.3-22.42%-2.02-184.31%-0.4334.78%-0.4512.68%-0.6231.17%-0.53
Diluted earnings per share 38.12%-1.2516.28%-0.3633.33%-0.353.23%-0.2943.40%-0.3-22.42%-2.02-193.48%-0.4334.78%-0.4512.68%-0.6231.17%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg